Since 2004, more American and Canadian soldiers have died from PTSD-related suicide than from combat itself, a statistic the film puts on screen before introducing its two subjects. Both are American veterans who have already tried the standard treatments for PTSD, therapy, medication, and other programs, without lasting relief. The film follows them to MAPS, the Multidisciplinary Association for Psychedelic Studies, and into MDMA-assisted therapy sessions, where the drug is used under clinical supervision alongside talk therapy rather than as a street substance. Interviews with the veterans trace what their symptoms look like day to day and how the sessions change their ability to function, sleep, and relate to family. The film does not shy away from the material: a note up front warns of a few scenes with graphic content. MAPS staff and researchers appear alongside the veterans to explain the therapy's protocol and the regulatory fight to get it approved. The stakes are plainly stated at the start and never really leave the frame.